Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Open Label Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

NCT04076943 is registered in ClinicalTrials.gov with Kyntra Bio as lead sponsor.

NCT NCT04076943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04076943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Open Label Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
Lead sponsor
Kyntra Bio
Phase
Phase 2
Overall status
Completed
Start date
August 20, 2019
Completion date
April 23, 2021
Enrollment
92 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced anemia